Therefore, it is of interest to evaluate the expression of HIF-1α andHIF-2α proteins to correlate with clinical outcomes in patients with head and neck squamous cell carcinoma (HNSCC). This evidence concerns the gene HIF1A and head and neck squamous cell carcinoma.